Clinical trial
A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell…
NCT00360087 · Actelion, Industry · Terminated
Key facts
| NCT number | NCT00360087 |
|---|---|
| Title | A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Study |
| Official title | Long-Term, Open-Label, Multicenter, Extension Study of Bosentan in Patients With Pulmonary Hypertension Associated With Sickle Cell Disease Completing a Double-Blind ASSET Study (AC-052-368 or AC 052-369) |
| Acronym | ASSET-3 |
| Lead sponsor | Actelion, Industry |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Hypertension, Sickle Cell Anemia |
| Intervention type | Drug |
| Interventions | Bosentan |
| Enrollment | 236 |
| Start date | Mar 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Aug 3, 2006 |
| Last update posted | Feb 3, 2025 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: